Glaxo Wellcome agreed to pay the University royalties on the worldwide sale of Ziagen, an AIDS-inhibiting drug, University President Mark Yudof announced Tuesday. About two-thirds of the royalty ...

The recent success of Imitrex-the antimigraine drug made by Glaxo Wellcome Inc. of Research Triangle Park, N.C.-has ignited a fury of pharmaceutical research. Imitrex (generic: sumatriptan) is the ...

Donald McDonnell, Glaxo-Wellcome distinguished professor of molecular cancer biology, described this as the “most unsettling time in [his] career,” stressing that a pause on grant-review ...

The merger of Wellcome and Glaxo in 1995 left the Wellcome Trust with a 4.7% stake in the new company, Glaxo-Wellcome, and it now has an asset base of more than £12 billion. Research grant ...

lead scientists Steven Kliewer, Tim Willson, and Jürgen Lehmann discovered a possible causal connection between diabetes and obesity. Jüergen M. Lehmann and the team of investigators at Glaxo Wellcome ...

ompany Biostructure and built partnerships with companies such as Glaxo Wellcome. Worth £450 million at the height of the biotech boom of the late 1990s, Oxford Molecular was sold for £70 ...

At first glance, there's not much difference between GlaxoSmithKline and AstraZeneca. Both are massive UK-listed drug companies. Both are popular with defensive investors. But when it comes to ...